Literature DB >> 23033927

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group.

Osnat Bairey1, Neta Goldschmidt, Rosa Ruchlemer, Tamar Tadmor, Neomi Rahimi-Levene, Mona Yuklea, Lev Shvidel, Alain Berrebi, Aaron Polliack, Yair Herishanu.   

Abstract

An insect-bite-like reaction is known to occur in patients with chronic lymphocytic leukemia (CLL). Most of the literature, however, consists of isolated case reports or small case series. The aim of this retrospective study was to review the national experience with insect-bite-like reaction in a large group of patients with CLL. The study cohort of patients with these skin reactions consisted of 48 patients (25 males, 23 females) of mean age 64.8 yr (range 33-89) at skin eruption. Data on clinical, histologic, immunophenotypic, and cytogenetic characteristics, treatment, and outcome were collected from the medical files. Mean time between diagnosis of CLL and appearance of the skin lesions was 3.1 yr (range -4 to 14 yr). The eruption was not related to disease activity or the course of the hematological disease. The eruption preceded the diagnosis of CLL in 10 patients (by 0-4 yr); and followed the diagnosis in 36; in 11 patients, it occurred during therapy for CLL and in nine after therapy. Mean duration of the skin findings was 21.5 months (range 0.3-132). The eruption usually presented in summer, although it occurred also at other times of the year, and predominantly affected the upper and lower limbs, although it also appeared on unexposed areas. Treatment included local ointments, antihistaminics, oral steroids, antibiotics, phototherapy, and dapsone with varying responses. Insect-bite-like reactions is a relatively common and disturbing skin reaction in CLL patients, it may be related to the immune dysregulation accompanying CLL and further exacerbated by external factors, including actual insect bites, chemoimmunotherapy, and pyogenic infection.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033927     DOI: 10.1111/ejh.12015

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  10 in total

1.  Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia.

Authors:  Gopisree Peringeth; Suchitra Sundaram; Paul Bogner; Elizabeth Conroy; Pallawi Torka
Journal:  Ann Hematol       Date:  2020-03-19       Impact factor: 3.673

2.  TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Authors:  Patricia K A Mongini; Rashmi Gupta; Erin Boyle; Jennifer Nieto; Hyunjoo Lee; Joanna Stein; Jela Bandovic; Tatjana Stankovic; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

3.  Insect bite-like reaction in a patient with T-cell lymphoma.

Authors:  Tatsuhiko Mori; Kinuko Irie; Toshiyuki Yamamoto
Journal:  An Bras Dermatol       Date:  2022-09-08       Impact factor: 2.113

4.  Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?

Authors:  Jianjun Qiao; Chang-E Sun; Weifang Zhu; Dingxian Zhu; Hong Fang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

5.  Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.

Authors:  Omar Bari; Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2017-07-31

6.  Insect Bite-Like Reaction with Bullous Lesions Mimicking Bullous Pemphigoid in a Patient with Chronic Lymphocytic Leukemia.

Authors:  Jee Eun Kim; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

7.  Chronic Pruritus Responding to Dupilumab-A Case Series.

Authors:  Lisa L Zhai; Kevin T Savage; Connie C Qiu; Annie Jin; Rodrigo Valdes-Rodriguez; Nicholas K Mollanazar
Journal:  Medicines (Basel)       Date:  2019-06-29

8.  Haematologic-Related Malignancy-Induced Eosinophilic Dermatoses (He Remained): A Narrative Review.

Authors:  Bikash Ranjan Kar; Akash Agarwal
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

9.  Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.

Authors:  Annie Jin; Bobak T Pousti; Kevin T Savage; Nicholas K Mollanazar; Jason B Lee; Sylvia Hsu
Journal:  JAAD Case Rep       Date:  2019-08-30

Review 10.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.